课题基金 / 基金详情

Cancer Research Career Enhancement and Related Activities

Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
批准号:
10254096
负责人:
CHRISTOPHER J. BAKKENIST
金额:
$7.53万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-09-10 至 2025-07-31

项目摘要

项目成果

CHRISTOPHER J. BAKKENIST的其他基金

相似基金

相关文献

中文摘要
翻译
摘要:职业提升及相关活动 UPMC希尔曼癌症中心(HCC)的一项重大战略举措是开发一个训练有素,多样化的 通过研究教育,培训和职业发展活动,促进生物医学劳动力, 了解癌症的生物学和治疗。为此,HCC卓越委员会 癌症教育和培训(CECET)每年举行4次会议,审查癌症教育和培训的广度、深度、可及性, 提高现有教育和培训机会的有效性,并根据需要制定新的方案。 CECET在海外的HCC投资约为140万美元/年,用于教育和培训。我们的工作是通过 三个主要的具体目标,旨在提供整个生物医学培训的职业提升机会 渠道.第一个目标是教育和激励高中和本科生的职业生涯, 癌症研究的重点是为代表性不足的人群服务。希尔曼学院提供了一个 8-为期一周的暑期实习,向433名高中生介绍癌症研究职业,其中包括175名 (40%)代表性不足的少数民族和弱势群体(URM/DA)在我们的集水区(CA)。该学院是 由多丽丝杜克慈善基金会,治愈和杰克肯特基金会支持,并授予一个 新的R25CA236620允许URM/DA学生人数立即增加70%。这个新 R25CA236620还提供支持,以提高我们周围社区的科学素养, 开展为期一天的研讨会,包括动手实践活动、设施图尔斯参观和癌症职业研讨会 research.我们的第二个目标是鼓励医学和博士生以及临床和博士后 研究员从事癌症研究的职业。我们利用HCC慈善事业招募了第一批 希尔曼医学生和博士后研究员创新癌症研究。我们加大 NCI T32培训补助金的数量从4个增加到6个,以支持所有CCSG项目的癌症研究重点。我们 对研究生研究员(GSR)教育的承诺证明了我们对更多GSR的支持, 任何其他皮特SOM学院或部门。应新成立的HCC博士后协会的要求, 我们已经建立了一个新的补助金写作类,量身定制K99 R00应用程序的NCI。这一举措建立了 F30、F31、F99 K00和K00 R01的成功经验。我们将扩大我们的希尔曼研究员为创新 癌症研究计划纳入一个新的"桥梁教师"的立场,将保证教师的立场时, 实现了关键指标。我们的第三个目标是通过广泛的, 多方面的教师指导计划,消除了创新癌症研究的障碍, 加强R01对NCI的应用。我们还将在整个网络中加大努力,确保平等 我们的医疗保健提供者获得特殊的癌症教育和培训计划,如 通过消除种族主义和公平以及AP-POWER(R25CA148050)对癌症护理负责。
英文摘要
Abstract: Career Enhancement and Related Activities A major strategic initiative for UPMC Hillman Cancer Center (HCC) is to develop a well-trained, diverse biomedical workforce through research education, training, and career-development activities that promote the understanding of the biology and treatment of cancer. To this end, the HCC Committee for Excellence in Cancer Education and Training (CECET) meets 4 times a year to review the breadth, depth, accessibility, and effectiveness of available education and training opportunities and to develop new programs as needed. CECET overseas an HCC investment of ~$1.4M/year in education and training. Our work is organized through three main specific aims designed to provide career enhancement opportunities across the biomedical training pipeline. The first aim is to educate and inspire high school and undergraduate students about careers in cancer research with a focus on serving underrepresented populations. The Hillman Academy has provided an 8-week summer internship introducing careers in cancer research to 433 high school students, including 175 (40%) underrepresented minority and disadvantaged (URM/DA) in our catchment area (CA). The Academy is supported by the Doris Duke Charitable Foundation, CURE and the Jack Kent Foundation, and the award of a new R25CA236620 allows an immediate 70% increase in the number of URM/DA students. This new R25CA236620 also provides support to improve the science literacy of our surrounding community by developing 1-day workshops that include hands-on activities, tours of facilities, and career seminars on cancer research. Our second aim is to encourage medical and doctoral students as well as clinical and postdoctoral fellows to pursue careers in cancer research. We have used HCC philanthropy to recruit the first class of Hillman Medical Student and Postdoctoral Fellows for Innovative Cancer Research. We have increased the number of NCI T32 training grants from 4 to 6 to support the cancer research focus of all CCSG programs. Our commitment to graduate student researcher (GSR) education is evidenced by our support of more GSRs than any other Pitt SOM Institute or Department. At the request of the newly formed HCC postdoctoral association, we have established a new grant writing class that tailors K99 R00 applications to the NCI. This initiative builds on previous F30, F31, F99 K00 and K00 R01 successes. We will extend our Hillman Fellows for Innovative Cancer Research program into a new “Bridge to Faculty” positions that will guarantee faculty positions when key metrics are attained. Our third aim is to enhance the professional growth of faculty through an extensive, multi-faceted faculty mentorship program that eliminates barriers to innovative cancer research and strengthens R01 applications to the NCI. We will also increase efforts across our network to ensure equal access of our health care providers to exceptional cancer education and training programs, such as Accountability for Cancer Care through Undoing Racism and Equity and AP-POWER (R25CA148050).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DNA damage response and cancer immunity
DNA damage response and cancer immunity
The UPMC Hillman Cancer Center Academy
DNA damage signaling to dormant origins of replication
海外基金